<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04353570</url>
  </required_header>
  <id_info>
    <org_study_id>10477M-IMPA</org_study_id>
    <nct_id>NCT04353570</nct_id>
  </id_info>
  <brief_title>Psychological Impact of Confinement on the Adult</brief_title>
  <acronym>IMPA</acronym>
  <official_title>Psychological Impact of Confinement on the Adult Population Followed in Outpatient Psychiatry at EPS Ville Evrard: Three-month Longitudinal Clinical Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de Ville-Evrard, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de Ville-Evrard, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical interview is made to allow a clinical follow-up of the patients followed in
      psychiatry of the EPS Ville-Evrard establishment in a simple way and in a secure medical
      framework during the period of the epidemic and the confinement from March 30 to June 30,
      2020.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 18, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Depression MINI DIAG and Anxiety questionnaire and the The Global Performance Rating Scale and CGI-truth</measure>
    <time_frame>three month</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">2100</enrollment>
  <condition>Identify the Psychological Impact of Containment</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>clinical interview</intervention_name>
    <description>This interview can be carried out face to face or remotely. In the latter case, it is part of telemedicine, which is recognised by the health authorities in France.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient followed in outpatient psychiatry at EPS Ville Evrard
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patient followed in outpatient psychiatry at EPS Ville Evrard and agrees to
        participate -

        Exclusion Criteria:

        Adult patient followed in outpatient psychiatry at EPS Ville Evrard and does not wish to
        participate

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Youcef BENCHERIF</last_name>
    <phone>0782723674</phone>
    <email>youcef.bencherif@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Unité de recherche clinique</name>
      <address>
        <city>Neuilly Sur Marne</city>
        <state>Île De France</state>
        <zip>93330</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BENCHERIF, CRA</last_name>
      <phone>0143093232</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre hospitalier de Ville-Evrard, France</investigator_affiliation>
    <investigator_full_name>Januel</investigator_full_name>
    <investigator_title>clinical research unit director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

